Japan vs Norway: Measles-containing-vaccine second-dose (MCV2) immunization coverage
Japan
95.0%
in 2025
Norway
95.0%
in 2025
Japan rank
29th
Norway rank
29th
Measles-containing-vaccine second-dose (MCV2) immunization coverage over time
- Japan
- Norway
How they compare
Japan currently reports 95.0% against 95.0% in Norway, a difference of 0.0%.
The two have swapped places 6 times across 26 shared years of data; in 2000 it was Norway ahead.
Japan ranks 29th and Norway ranks 29th of 194 countries.
Across the 3 decades both report, Japan averaged higher in 2 and Norway in 1.
Head to head by decade
| Decade | Japan | Norway | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 17.0% | 91.5% | 74.5% | Norway |
| 2010s | 93.5% | 92.6% | 0.9% | Japan |
| 2020s | 94.8% | 94.5% | 0.3% | Japan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher measles-containing-vaccine second-dose (mcv2) immunization coverage, Japan or Norway?
- Japan, at 95.0% against 95.0% in Norway as of 2025.
- What is the difference in measles-containing-vaccine second-dose (mcv2) immunization coverage between Japan and Norway?
- 0.0%, with Japan ahead.
- How many years of comparable data are there for Japan and Norway?
- 26 years are reported by both, from 2000 to 2025.
- How do Japan and Norway rank globally for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Japan ranks 29th and Norway ranks 29th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.